Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai has announced plans for a new $90 million pharmaceutical R&D facility to support the development and production of the company's intravenous oncology treatments.
Subscribe to our email newsletter
The new 65,000 square foot facility will extend Eisai’s capability at the Research Triangle Park in North Carolina, and will encompass aseptic processing suites, laboratories and other support functions.
In addition, a separate $15 million central utilities building is planned to supply power, steam, chilled water and compressed air to the existing operations and the new facility.
The development is expected to begin in the fall and completion is anticipated in three years with operations beginning in 2009. The new facilities will lead to 59 new jobs over the next three years and a total of 84 new jobs over the next five years, the company said.
“The new buildings will complement the existing R&D operations and enhance our capability to develop and produce intravenous drug product in support of our clinical development programs in oncology,” said Ray Wood, vice president of Pharmaceutical and Analytical R&D, Eisai.